|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
|
 |
|
|
New Leaf Venture Partners
Offices: Menlo Park, California & New
York, New York
New Leaf Venture Partners is a leader in
healthcare technology venture investing.
Their investment professionals bring a unique
blend of technological, clinical, and operational
experience to their investments. They work
closely with their entrepreneurs to help
build successful portfolio companies. They
focus primarily on later stage biopharmaceutical
products, early stage medical devices, and
laboratory infrastructure technologies.
|
Nexus Medical Partners (NMP)
Offices: Boston, Massachusetts
Nexus Medical Partners is a private equity
firmspecializing in making private equity
investments in and providing strategic assistance
to medical technology and selected life
science companies. Each of the Nexus Principals
averages twenty years in the business. In
addition to being experienced equity investors,
the backgrounds of the Principals include
successful careers in medical device and
pharmaceutical line management of both established
and emerging companies, medical industry
business development, Wall Street analysis
and legal practice. |
Nomura Phase4 Ventures
Offices: Stockholm, Sweden
Phase4 Ventures is a global life science
investor whose mission is to provide a premium
rate of return for investors by creating,
identifying and investing in development
stage healthcare companies through its dedicated
fund. Phase4 Ventures invests in biopharma,
specialty pharmaceutical and medical device
companies in the US and Europe. The team
of seven investment professionals has experience
in medical, scientific, legal and financial
disciplines, with a core expertise in structuring
investments appropriate for the stage of
the company. |
Novartis Venture Fund
Offices: Basel, Switzerland & San Diego,
California
The Novartis Venture Fund is based on the
conviction that economic growth and the
creation of new jobs can be achieved in
the long run only if new entrepreneurial
initiatives develop and promising ideas
become business reality. With a venture
capital of CHF 150 million and USD 100 million,
the Fund supports new business projects
that show exemplary entrepreneurial and
innovative spirit in future-oriented areas,
especially in the field of Health Sciences |
|
|
Oakwood Medical Investors
Offices: St Louis, Missouri & Cleveland,
Ohio
Oakwood Medical Investors is a life science
venture capital fund formed to invest in
development stage medical device, biotechnology,
pharmaceutical and medical service companies.
Target portfolio companies for Oakwood have
an outstanding management team, industry
disruptive technology, demonstrated proof
of principal and have typically completed
a first round of institutional venture financing.
|
OrbiMed
Offices: New York, New York
OrbiMed is a preeminent asset management
firm focused exclusively on the global health
sciences industry, with over $5 billion
in assets under management across a family
of private equity funds, hedge funds and
other investment vehicles. OrbiMed's investment
advisory activities were founded in 1989
by Samuel D Isaly with a vision to invest
across the industry spectrum: from small
privately-held drug discovery and medical
device companies to large publicly-traded
global pharmaceutical companies. |
Oxford Bioscience Partners (OBP)
Offices: Boston, Massachusetts; Westport,
Connecticut & Costa Mesa, California
Oxford Bioscience Partners is a life science
venture capital firm that provides equity
financing and management assistance to start-up
and early-stage, entrepreneurial-driven
companies in the bioscience and healthcare
industries. The general partners of OBP
currently manage venture funds with committed
capital of more than $800 million. The objective
of OBP is to generate long-term capital
gains for both the investors in the Fund
and the entrepreneurs that they support. |
|
|
|
|
|
|
|
Bio
Life (-Pacific-)
Resources
to
top